GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » West Island Brands Inc (XCNQ:WIB) » Definitions » Debt-to-EBITDA

West Island Brands (XCNQ:WIB) Debt-to-EBITDA : -1.03 (As of Sep. 2022)


View and export this data going back to 2012. Start your Free Trial

What is West Island Brands Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

West Island Brands's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was C$0.56 Mil. West Island Brands's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was C$1.11 Mil. West Island Brands's annualized EBITDA for the quarter that ended in Sep. 2022 was C$-1.62 Mil. West Island Brands's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2022 was -1.03.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for West Island Brands's Debt-to-EBITDA or its related term are showing as below:

XCNQ:WIB's Debt-to-EBITDA is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.7
* Ranked among companies with meaningful Debt-to-EBITDA only.

West Island Brands Debt-to-EBITDA Historical Data

The historical data trend for West Island Brands's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

West Island Brands Debt-to-EBITDA Chart

West Island Brands Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -0.14 -0.15 -0.35

West Island Brands Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.23 -0.15 -1.37 -1.42 -1.03

Competitive Comparison of West Island Brands's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, West Island Brands's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


West Island Brands's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, West Island Brands's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where West Island Brands's Debt-to-EBITDA falls into.



West Island Brands Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

West Island Brands's Debt-to-EBITDA for the fiscal year that ended in Dec. 2021 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.554 + 1.153) / -4.863
=-0.35

West Island Brands's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.558 + 1.109) / -1.624
=-1.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2022) EBITDA data.


West Island Brands  (XCNQ:WIB) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


West Island Brands Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of West Island Brands's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


West Island Brands (XCNQ:WIB) Business Description

Traded in Other Exchanges
N/A
Address
44 Victoria Street, Suite 1102, Toronto, ON, CAN, M5C 1Y2
West Island Brands Inc is a Canadian holding company, operating in the vertically integrated cannabis space. The company sells and distributes recreational and medical cannabis through a subsidiary, West Island Culture. The firm operates out of its cultivation and processing facility in Dorval, Quebec. The company sells cannabis products under the OUEST and CITOYEN brands.

West Island Brands (XCNQ:WIB) Headlines

No Headlines